ICD-10 Coding for Dyskinesia(G20.11, G20.11N, G20.11P)
Explore detailed ICD-10 coding for dyskinesia, including drug-induced and Parkinson's-related cases. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Dyskinesia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G24.01 | Drug-induced subacute dyskinesia | Use for tardive dyskinesia induced by neuroleptic drugs. |
|
| G20.11 | Parkinson's disease with dyskinesia | Use for Parkinson's disease patients experiencing dyskinesia. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutDyskinesia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Dyskinesia.
Omitting drug history in dyskinesia documentation
Impact
Clinical: Inaccurate treatment planning, Regulatory: Non-compliance with documentation standards, Financial: Potential claim denials
Mitigation
Include detailed medication history in notes, Use templates to ensure completeness
Using G24.01 for non-drug-induced dyskinesia
Impact
Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure documentation specifies drug-induced nature.
Incomplete documentation of drug-induced dyskinesia
Impact
Failure to document drug history and AIMS scores.
Mitigation
Implement regular documentation audits and training.